Agriculture Investments Crop Protection Funding Round

Source Agriculture Corp. Invests in Ascribe Bioscience for Sustainable Crop Protection Solutions

Source Agriculture Corp. announces a strategic investment in Ascribe Bioscience, a company specializing in sustainable crop protection. Agriculture News, AgTech News, AgTech.
Photo by Dani California on Unsplash

Key Points:

  • Source Agriculture Corp. announces a strategic investment in Ascribe Bioscience, a company specializing in sustainable crop protection.
  • Ascribe’s flagship product, Phytalix®, primes plants’ immune systems to combat pathogens naturally.
  • Phytalix® offers a non-toxic, biodegradable, and non-GMO alternative to traditional pesticides.
  • Ascribe’s platform leverages advanced metabolomics to develop durable, shelf-stable biobased solutions.
  • The partnership aligns with Source Agriculture’s mission to support innovative, environmentally friendly agricultural technologies.

Advancing Sustainable Agriculture with Ascribe Bioscience

Source Agriculture Corp. (Company Profile) has announced its strategic investment in Ascribe Bioscience (Company Profile). Founded in 2017, Ascribe is dedicated to creating sustainable crop protection technologies based on natural molecules derived from the soil microbiome.

The company’s flagship product, Phytalix®, acts as a plant vaccine by priming natural defense systems to combat pathogens. Proven to be effective across various crops such as corn, wheat, soy, rice, potatoes, and tomatoes, Phytalix® represents an environmentally responsible alternative to traditional chemical pesticides.


Key Features of Phytalix®

Environmentally Friendly and Effective

Phytalix® is derived from naturally occurring molecules produced by soil organisms. The product is:

  • Non-toxic, ensuring safety for farmers and ecosystems.
  • Biodegradable, minimizing environmental impact.
  • Non-GMO, appealing to growers seeking sustainable options.
How It Works

By triggering the plant’s immune system, Phytalix® enhances crops’ ability to respond rapidly to stressors like pathogens. It can be applied as a seed treatment or foliar spray, requiring minimal active ingredient per acre, reducing costs, and improving sustainability.


Ascribe’s Innovative Platform

Ascribe Bioscience’s proprietary platform uses advanced metabolomics to explore the soil microbiome, identifying small molecules that boost plant health and productivity. Unlike traditional biological treatments that rely on live microbes, Ascribe’s biobased products are:

  • Shelf-stable for extended usability.
  • Reliable under diverse field conditions.
  • Cost-effective, offering consistent performance compared to complex biological mixtures.

Supporting Sustainable Agriculture

Aman Gill, President and CEO of Source Agriculture Corp., emphasized the significance of this investment: “We believe that Ascribe Bioscience’s approach represents the future of sustainable crop protection. Their innovative platform and commitment to natural, effective solutions align perfectly with Source Agriculture’s mission to support technologies that not only improve farming productivity but also contribute to environmental sustainability.”

This investment strengthens Source Agriculture’s portfolio of companies focused on advancing sustainable and high-tech farming practices. The collaboration with Ascribe is expected to support farmers worldwide by providing innovative solutions that reduce dependence on harmful chemicals while improving crop productivity.

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

Leave a Reply